Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Association of SULT1A1 Arg²¹³His polymorphism with male breast cancer risk: results from a multicenter study in Italy.

Ottini L, Rizzolo P, Zanna I, Silvestri V, Saieva C, Falchetti M, Masala G, Navazio AS, Capalbo C, Bianchi S, Manoukian S, Barile M, Peterlongo P, Caligo MA, Varesco L, Tommasi S, Russo A, Giannini G, Cortesi L, Cini G, Montagna M, Radice P, Palli D.

Breast Cancer Res Treat. 2014 Dec;148(3):623-8. doi: 10.1007/s10549-014-3193-2. Epub 2014 Nov 11.

PMID:
25385181
2.

Immortalization of human adipose-derived stromal cells: production of cell lines with high growth rate, mesenchymal marker expression and capability to secrete high levels of angiogenic factors.

Balducci L, Blasi A, Saldarelli M, Soleti A, Pessina A, Bonomi A, Coccè V, Dossena M, Tosetti V, Ceserani V, Navone SE, Falchetti ML, Parati EA, Alessandri G.

Stem Cell Res Ther. 2014 May 6;5(3):63. doi: 10.1186/scrt452.

3.

Mutational profiling in melanocytic tumors: multiple somatic mutations and clinical implications.

Richetta AG, Silvestri V, Giancristoforo S, Rizzolo P, D'Epiro S, Graziano V, Mattozzi C, Navazio AS, Falchetti M, Calvieri S, Ottini L.

Oncology. 2014;86(2):104-8. doi: 10.1159/000356878. Epub 2014 Jan 18.

PMID:
24457427
4.

Male breast cancer: genetics, epigenetics, and ethical aspects.

Rizzolo P, Silvestri V, Tommasi S, Pinto R, Danza K, Falchetti M, Gulino M, Frati P, Ottini L.

Ann Oncol. 2013 Nov;24 Suppl 8:viii75-viii82. doi: 10.1093/annonc/mdt316. Review.

5.

Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy.

Bellone S, Tassi R, Betti M, English D, Cocco E, Gasparrini S, Bortolomai I, Black JD, Todeschini P, Romani C, Ravaggi A, Bignotti E, Bandiera E, Zanotti L, Pecorelli S, Ardighieri L, Falchetti M, Donzelli C, Siegel ER, Azodi M, Silasi DA, Ratner E, Schwartz PE, Rutherford TJ, Santin AD.

Br J Cancer. 2013 Jul 23;109(2):462-71. doi: 10.1038/bjc.2013.315. Epub 2013 Jun 27.

6.

SULT1A1 gene deletion in BRCA2-associated male breast cancer: a link between genes and environmental exposures?

Palli D, Rizzolo P, Zanna I, Silvestri V, Saieva C, Falchetti M, Navazio AS, Graziano V, Masala G, Bianchi S, Russo A, Tommasi S, Ottini L.

J Cell Mol Med. 2013 May;17(5):605-7. doi: 10.1111/jcmm.12043.

7.

Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in Italy.

Ottini L, Silvestri V, Saieva C, Rizzolo P, Zanna I, Falchetti M, Masala G, Navazio AS, Graziano V, Bianchi S, Manoukian S, Barile M, Peterlongo P, D'Amico C, Varesco L, Tommasi S, Russo A, Giannini G, Cortesi L, Viel A, Montagna M, Radice P, Palli D.

Breast Cancer Res Treat. 2013 Apr;138(3):861-8. doi: 10.1007/s10549-013-2459-4. Epub 2013 Mar 7.

PMID:
23468243
8.

Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice.

Pessina A, Coccè V, Pascucci L, Bonomi A, Cavicchini L, Sisto F, Ferrari M, Ciusani E, Crovace A, Falchetti ML, Zicari S, Caruso A, Navone S, Marfia G, Benetti A, Ceccarelli P, Parati E, Alessandri G.

Br J Haematol. 2013 Mar;160(6):766-78. doi: 10.1111/bjh.12196. Epub 2013 Jan 7.

PMID:
23293837
9.

[Fire worship on Soratte: form prehistory to present days].

Falchetti M, Ottini L.

Med Secoli. 2013;25(2):609-36. Italian.

PMID:
25807785
10.

[Medical research through historical resources. Talking objects: a case of a parasitic perineal monstrosity].

Ottini L, Franza A, Rizzolo P, Falchetti M, Santi R, Nesi G.

Med Secoli. 2013;25(1):267-94. Italian.

PMID:
25807709
11.

Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma.

Bignotti E, Zanotti L, Calza S, Falchetti M, Lonardi S, Ravaggi A, Romani C, Todeschini P, Bandiera E, Tassi RA, Facchetti F, Sartori E, Pecorelli S, Roque DM, Santin AD.

BMC Clin Pathol. 2012 Nov 14;12:22. doi: 10.1186/1472-6890-12-22.

12.

Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma.

Cenci T, Martini M, Montano N, D'Alessandris QG, Falchetti ML, Annibali D, Savino M, Bianchi F, Pierconti F, Nasi S, Pallini R, Larocca LM.

Am J Clin Pathol. 2012 Sep;138(3):390-6. doi: 10.1309/AJCPRXHNJQLO09QA.

13.

Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy.

Ottini L, Silvestri V, Rizzolo P, Falchetti M, Zanna I, Saieva C, Masala G, Bianchi S, Manoukian S, Barile M, Peterlongo P, Varesco L, Tommasi S, Russo A, Giannini G, Cortesi L, Viel A, Montagna M, Radice P, Palli D.

Breast Cancer Res Treat. 2012 Jul;134(1):411-8. doi: 10.1007/s10549-012-2062-0. Epub 2012 Apr 18.

PMID:
22527108
14.

Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy.

Pessina A, Bonomi A, Coccè V, Invernici G, Navone S, Cavicchini L, Sisto F, Ferrari M, Viganò L, Locatelli A, Ciusani E, Cappelletti G, Cartelli D, Arnaldo C, Parati E, Marfia G, Pallini R, Falchetti ML, Alessandri G.

PLoS One. 2011;6(12):e28321. doi: 10.1371/journal.pone.0028321. Epub 2011 Dec 20.

15.

Oxygen sensing is impaired in ATM-defective cells.

Mongiardi MP, Stagni V, Natoli M, Giaccari D, D'Agnano I, Falchetti ML, Barilà D, Levi A.

Cell Cycle. 2011 Dec 15;10(24):4311-20. doi: 10.4161/cc.10.24.18663. Epub 2011 Dec 15.

PMID:
22134239
16.

Trop-2 overexpression in poorly differentiated endometrial endometrioid carcinoma: implications for immunotherapy with hRS7, a humanized anti-trop-2 monoclonal antibody.

Bignotti E, Ravaggi A, Romani C, Falchetti M, Lonardi S, Facchetti F, Pecorelli S, Varughese J, Cocco E, Bellone S, Schwartz PE, Rutherford TJ, Santin AD.

Int J Gynecol Cancer. 2011 Dec;21(9):1613-21. doi: 10.1097/IGC.0b013e318228f6da.

17.

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients.

Bignotti E, Ragnoli M, Zanotti L, Calza S, Falchetti M, Lonardi S, Bergamelli S, Bandiera E, Tassi RA, Romani C, Todeschini P, Odicino FE, Facchetti F, Pecorelli S, Ravaggi A.

Br J Cancer. 2011 Apr 26;104(9):1418-25. doi: 10.1038/bjc.2011.109. Epub 2011 Apr 5.

18.

Mutation screening of RAD51C in male breast cancer patients.

Silvestri V, Rizzolo P, Falchetti M, Zanna I, Masala G, Palli D, Ottini L.

Breast Cancer Res. 2011 Feb 8;13(1):404. doi: 10.1186/bcr2823. No abstract available.

19.

PRKCSH GAG trinucleotide repeat is a mutational target in gastric carcinomas with high-level microsatellite instability.

Palmirotta R, Guadagni F, Savonarola A, Ludovici G, De Marchis ML, Palli D, Falchetti M, Ottini L.

Clin Genet. 2011 Apr;79(4):397-8; author reply 399-400. doi: 10.1111/j.1399-0004.2010.01536.x. No abstract available.

PMID:
21371016
20.

PAI-1 4G/5G repeat is a target in gastric carcinomas with microsatellite instability.

Palmirotta R, Guadagni F, Savonarola A, Ludovici G, Nesi G, Palli D, Falchetti M, Ottini L.

Dig Liver Dis. 2011 Jun;43(6):454-8. doi: 10.1016/j.dld.2010.12.002. Epub 2011 Jan 8.

PMID:
21216681
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk